Related Experiment Video

Updated: Feb 8, 2026

Experimental Paradigm for Measuring the Effects of Self-distancing in Young Children
07:01

Experimental Paradigm for Measuring the Effects of Self-distancing in Young Children

Published on: March 1, 2019

8.5K

A new paradigm for developing drugs in children: atomoxetine as a model

S Prasad1

  • 1Eli Lilly and Company, Priestley Road, Basingstoke, Hampshire RG24 9NL, UK. suyash@lilly.com

Archives of Disease in Childhood
|January 25, 2005
PubMed

Insights

Developing atomoxetine for pediatric attention deficit/hyperactivity disorder (ADHD) required specific trials. These studies confirmed the drug

Area of Science:

  • Pharmacology and Clinical Trials
  • Pediatric Drug Development
  • Neurodevelopmental Disorders

Background:

  • Children possess distinct physiology and metabolism compared to adults, necessitating tailored drug development.
  • Pediatric drug trials face unique challenges, including practical, ethical, and communication considerations.
  • Establishing safety and efficacy in pediatric populations is crucial for medications with pediatric indications.

Purpose of the Study:

  • To outline the drug development process for atomoxetine, a non-stimulant ADHD medication, specifically focusing on its pediatric application.
  • To highlight the methodologies employed in assessing the safety and efficacy of atomoxetine in children.
  • To emphasize the importance of pediatric-specific clinical trials in drug development.

Main Methods:

  • Preclinical studies and adult trials preceded pediatric investigations.
  • Open-label and placebo-controlled studies were conducted in pediatric patients.
  • Ongoing trials continue to explore broader aspects of atomoxetine's effects in children.

Main Results:

  • Atomoxetine's safety and efficacy were established in pediatric patients with ADHD through clinical trials.
  • The drug development pathway included phased trials from preclinical to pediatric populations.
  • Evidence supports atomoxetine as a viable treatment option for pediatric ADHD.

Conclusions:

  • The development of atomoxetine demonstrates a rigorous approach to pediatric drug safety and efficacy assessment.
  • Paediatric clinical trials are essential for understanding drug responses in this unique population.
  • Further research continues to refine the understanding and application of atomoxetine in children with ADHD.

More Related Videos

Using the Visual World Paradigm to Study Sentence Comprehension in Mandarin-Speaking Children with Autism06:15

Using the Visual World Paradigm to Study Sentence Comprehension in Mandarin-Speaking Children with Autism

Published on: October 3, 2018

8.2K
The Modified Temptation Resistance Task: A Paradigm to Elicit Children's Strategic Lie-telling06:51

The Modified Temptation Resistance Task: A Paradigm to Elicit Children's Strategic Lie-telling

Published on: April 6, 2018

8.9K

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
295
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
335
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
309
Sustainable Development01:43

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K
Development of the Lymphatic System01:15

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.1K